Brendan Keating, D.Phil., Associate Professor of Transplantation Research in the Department of Surgery, at The University of Pennsylvania, USA.
Dr Brendan Keating received his D.Phil. in molecular genetics from the Department of Clinical Medicine at University of Oxford, UK. He completed a post-doctoral fellowship at the Institute of Translational Medicine and Therapeutics (ITMAT) at UPenn, and was a visiting Scientist at the Wellcome Trust Sanger Institute, Cambridge, UK.
His major research interests focus on the analyses of polymorphisms of transplant donor and recipient’s genomes, to discover and validate genomic signals that underpin graft rejection and complications of rejection.
He instigated the formation of an international genomics consortium (iGeneTRAIN) for large-scale genomic studies using > 51,000 patient samples from a number of international transplant studies (www.igenetrain.org). Dr. Keating is PI for of genome-wide studies of solid-organ transplant cohorts within UPenn and the Children’s Hospital of Philadelphia, and of a number of kidney and heart transplant omic studies.
Dr. Keating is also PI of a prospective NIH funded study looking at post-transplant outcomes in 12 North American pediatric renal transplant centers, and a number of international sites, and is also PI of a large NIH funded Heart Transplant mulitomics prospective study.